These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 18662736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Two cases of Guillain-Barré syndrome during measles elimination campaign in Izmir.
    Koturoglu G, Kurugol Z, Tekgul H, Ozcan T, Dizdarer C.
    Minerva Pediatr; 2008 Dec; 60(6):1455-7. PubMed ID: 18971907
    [Abstract] [Full Text] [Related]

  • 5. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N, Nasar A, Suri MF, Qureshi AI.
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 Jun 04; 59(21):657-61. PubMed ID: 20520590
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J.
    Int J Infect Dis; 2008 Jan 04; 12(1):43-6. PubMed ID: 17950020
    [Abstract] [Full Text] [Related]

  • 11. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM, Campbell-Lloyd S, Isaacs D, Gold M, Burgess M, Turnbull F, O'Brien E.
    Commun Dis Intell; 2000 Feb 17; 24(2):27-33. PubMed ID: 10758692
    [Abstract] [Full Text] [Related]

  • 12. The measles/rubella immunisation campaign in Scotland.
    Skinner R, Christie P, Cowden JM.
    Health Bull (Edinb); 1996 Jan 17; 54(1):88-98. PubMed ID: 8820234
    [Abstract] [Full Text] [Related]

  • 13. Recurrent Guillain-Barre syndrome following vaccination.
    Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP, CISA Network.
    Clin Infect Dis; 2012 Mar 17; 54(6):800-4. PubMed ID: 22267712
    [Abstract] [Full Text] [Related]

  • 14. Guillain-Barré syndrome: background incidence rates in The Netherlands.
    van der Maas NA, Kramer MA, Jacobs BC, van Soest EM, Dieleman JP, Kemmeren JM, de Melker HE, Sturkenboom MC.
    J Peripher Nerv Syst; 2011 Sep 17; 16(3):243-9. PubMed ID: 22003939
    [Abstract] [Full Text] [Related]

  • 15. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C, Rhie S, Suh M, Kang DR, Choi YJ, Bae GR, Choi YC, Jun BY, Lee JS.
    Vaccine; 2015 Apr 08; 33(15):1815-23. PubMed ID: 25728315
    [Abstract] [Full Text] [Related]

  • 16. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003.
    Hamkar R, Jalilvand S, Mokhtari-Azad T, Jelyani KN, Nategh R.
    Am J Infect Control; 2006 Nov 01; 34(9):588-92. PubMed ID: 17097454
    [Abstract] [Full Text] [Related]

  • 19. Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998-1999: the view from a sentinel network of neurologists.
    Cuadrado JI, de Pedro-Cuesta J, Ara JR, Cemillán CA, Díaz M, Duarte J, Fernández MD, Fernandez O, García-López F, García-Merino A, Velasquez JM, Martínez-Matos JA, Palomo F, Pardo J, Tobías A, Spanish GBS Epidemiological Study Group.
    Neurol Sci; 2004 Jun 01; 25(2):57-65. PubMed ID: 15221623
    [Abstract] [Full Text] [Related]

  • 20. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996.
    Bogliun G, Beghi E, Italian GBS Registry Study Group.
    Acta Neurol Scand; 2004 Aug 01; 110(2):100-6. PubMed ID: 15242417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.